改良早期预警评分系统联合急生生理和慢性健康评估系统评分在重症监护室患者早期病情评估中的应用

Application of MEWS combined with APACHE II score in patients with early stage disease assessment of ICU

目的:探讨改良早期预警评分系统(MEWS)联合急性生理和慢性健康评估系统(APACHEⅡ)评分在ICU患者早期病情评估中的临床应用价值。方法:选取收治的符合入选标准的患者184例为研究对象,按照随机数字法分为对照组92例及试验组92例。以患者入住ICU时即作为观察起点,采集相关数据,对照组进行APACHEⅡ评分,试验组进行MEWS和APACHEⅡ评分,比较两组患者24 h ICU内病死率、24 h ICU内心肺复苏率及ICU住院时间。结果:试验组24 h ICU内病死率、24 h ICU内心肺复苏率、ICU住院时间与对照组比较,差异有统计学意义(P<0.05)。结论:MEWS联合APACHEⅡ评分评价体系的建立与应用,能够在早期更加全面、快速、准确、简便地评估和判断ICU患者病情危重程度,并及早发现患者潜在的病情变化,为医护人员及时干预和处置急危重症患者提供数据化认证评估依据,从而提高院内危重症患者救治水平,规避医疗风险,值得临床推广应用。

Objective To explore the modified early warning score system （MEWS） combined with acute physiology and chronic health evaluation system （ APACHE II ） score in ICU patients early condition to evaluate the clinical application val-ue. Method 184 cases of patients meet the inclusion criteria of as the research object,according to the method of random Num-bers they were divided into control group 92 cases and experimental group 92 cases. To patients in the ICU was observed as a starting point,collecting relevant data,the control of APACHE II ratings,the experimental group simultaneously MEWS and A-PACHE II score,comparative analysis of two groups of patients within 24 h, cardiopulmonary resuscitation （CPR） within 24 h rate and fatality rate of ICU length of hospital stay. Results The experimental group within 24 h case fatality rate, rate of cardiop-ulmonary resuscitation （CPR） within 24 h,ICU length of hospital stay compared with the control group,the difference was statis-tically significant （P 〈0. 05）. Conclusion The establishment and application of the MEWS and APACHE II evaluation system, can be in early a more comprehensive, rapid, accurate, easy to evaluate and judge the degree of ICU patients in a critical condi-tion ,and early detection of potential patient change, for the medical personnel timely intervention and treatment of the critical pa-tients to provide digital certification assessment basis, so as to improve the level of critically ill patients in treatment and avoid medical risk,worthy of clinical popularization and application.